Head and Neck Cancer Drugs Market is projected to reach $2,281 million by 2025

Head & Neck Cancer Drugs Market Overview:
The global head & neck cancer drugs market was valued at $1,295 million in 2017 and is projected to reach $2,281 million by 2025, registering a CAGR of 7.3% from 2018 to 2025. 

Head & neck cancers include a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, lips, salivary glands and mouth. Head and neck squamous cell carcinoma (HNSCC) is the most common form of head & neck cancer, which develops in the mucous membranes of the mouth, nose, and throat. Chemotherapy, immunotherapy & targeted therapy are used for the treatment of head & neck cancer along with the radiation & surgical procedures.

There is an increase in the demand for head & neck cancer drugs owing to the growth in incidence of head & neck cancer, rise in demand for combination therapeutics, the higher number of R&D studies, and the surge in adoption of immune therapeutics. In addition, growth in the geriatric population and technological advancements in screening & diagnosis of head & neck cancer further drive the market growth. The strong presence of late-stage pipeline drugs such as Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib, Bevacizumab, and others are expected to drive market growth. However, higher cost & adverse effect associated with head & neck cancer drugs are projected to impede market growth.

The global head & neck cancer drugs market is segmented based on drug class, sales channel, and region. Based on drug class, the market is classified as chemotherapy, immunotherapy, and targeted therapy. According to the sales channel, the market is categorized as hospital pharmacies, drug stores and retail pharmacies, and online stores. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, and rest of LAMEA).

Key Benefits for Head & Neck Cancer Drugs Market:
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Head & Neck Cancer Drugs Key Market Segments:
By Drug Class 
Targeted Therapy

By Sales Channel 
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Stores

By Region
North America
Rest of Europe
South Korea
Rest of Asia-Pacific
Saudi Arabia
South Africa
Rest of LAMEA

List of Key Players Profiled in the Report:
AstraZeneca PLC
Bristol-Myers Squibb Company
Eli Lilly and Company (ARMO Biosciences.)
Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.)
F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
Immutep Limited
Merck & Co., Inc.
Merck KGaA (EMD Serono, Inc.)
Novartis AG
Pfizer Inc.

List of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request.)
Boehringer Ingelheim
AVEO Pharmaceuticals


Note: The study forecast period can be customize as per the request

Access this Report: https://www.reportocean.com/industry-verticals/sample-request?report_id=27328


About us:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports. We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization.

Contact us:
Company Name: Report Ocean
Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Person: Sandeep Singh
URL: www.reportocean.com
Email: sales@reportocean.com


Ronard Completed his Master in Communication, after completing his degree he opted full-time research as his career. Ronard Main Area of Specialization is Market Research, he also contributes to Various Online Blog

Leave a Reply

Your email address will not be published. Required fields are marked *

19 − fifteen =